Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02955290
Title CIMAvax Vaccine and Nivolumab in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Roswell Park Cancer Institute
Indications

lung non-small cell carcinoma

Therapies

CIMAvax-EGF + Nivolumab

Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Indiana University Melvin and Bren Simon Comprehensive Cancer Center Recruiting Indianapolis Indiana 46202 United States Details
Roswell Park Cancer Institute Recruiting Buffalo New York 14263 United States Details
St. Francis Hospital Recruiting Roslyn New York 11576 United States Details
Good Samaritan Hospital Recruiting West Islip New York 11795 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field